These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiogenesis regulated by VEGF and its receptors and its clinical application. Shibuya M Rinsho Ketsueki; 2009 May; 50(5):404-12. PubMed ID: 19483401 [No Abstract] [Full Text] [Related]
4. Anti-angiogenesis: the challenges ahead. Mariani SM MedGenMed; 2003 Apr; 5(2):22. PubMed ID: 14603121 [No Abstract] [Full Text] [Related]
5. A new weapon for attacking tumor blood vessels. Semenza GL N Engl J Med; 2008 May; 358(19):2066-7. PubMed ID: 18463385 [No Abstract] [Full Text] [Related]
6. [Bevacizumab and radiotherapy]. Blanchard P; Besse B; Deutsch E Rev Mal Respir; 2008 Dec; 25(10):1319-21. PubMed ID: 19107021 [No Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular toxicity of new agents. Maitland ML Clin Adv Hematol Oncol; 2008 Sep; 6(9):657-9. PubMed ID: 18827788 [No Abstract] [Full Text] [Related]
9. Promising early results for immunotherapy-antiangiogenesis combination. Garber K J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25421345 [No Abstract] [Full Text] [Related]
19. Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. Murukesh N; Dive C; Jayson GC Br J Cancer; 2010 Jan; 102(1):8-18. PubMed ID: 20010945 [TBL] [Abstract][Full Text] [Related]
20. [Inhibition of angiogenesis by proteins, peptides and "small molecules"]. Jayson G; Armand JP; Berdel WE Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103 [No Abstract] [Full Text] [Related] [Next] [New Search]